Johnson & Johnson
http://www.jnj.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Johnson & Johnson
Accelerated Approval: Withdrawing Gene Therapies Could Be Easier Than Small Molecules
The FDA would only withdraw a rare disease gene therapy for “pretty clear” reasons, such as when there is minimal benefit with extensive side effects. The one-and-done nature of administration also makes withdrawal easier, CBER Director Peter Marks says.
Kenvue Cutting Staff 4% After Year Apart From J&J
Along with latest results, Kenvue says as its “transitions services agreement” with J&J ends, its board approves reducing global workforce by around 4%. It expects around $275m in pre-tax restructuring costs in both 2024 and 2025 without changes to its capital allocation priorities.
Stock Watch: Core Business Drags As Roche Disappoints And Sanofi Reclassifies
After the volatility of pandemic-related sales, investor and analyst attention turned to pharma’s core businesses. With exclusivity losses weighing on those large components of pharma, Sanofi’s reclassification may bring some unwelcome attention.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abiomed, Inc.
- Acclarent Inc.
- Actelion Pharmaceuticals Ltd.
- AdvanceCOR GmbH
- ALZA Corporation
- Alios BioPharma, Inc.
- Animas Corporation
- Aragon Pharmaceuticals, Inc.
- Auris Health, Inc.
- Auris Surgical Robotics
- BeneVir Biopharm, Inc.
- BioMedical Enterprises, Inc.
- Biosense Webster, Inc.
- Calibra Medical, Inc.
- Centyrex Internal Venture
- Cilag AG
- Cerenovus
- Codman & Shurtleff, Inc
- Coherex Medical, Inc.
- Conor Medsystems, Inc.
- Cordis Webster, Inc.
- CorImmun GmbH
- Cougar Biotechnology, Inc.
- Covagen AG
- Crucell N.V.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Synthes, Inc.
- Ensure Medical
- Ethicon, Inc.
- FemRx Inc.
- Flexible Stenting Solutions, Inc.
- Gynecare, Inc.
- Hansen Medical, Inc.
- Innovative Surgical Solutions, LLC
- Interventional Spine, Inc.
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Janssen Diagnostics
- Janssen Pharmaceuticals
- Janssen Vaccines & Prevention B.V.
- JointPoint, Inc.
- LifeScan, Inc.
- Medical Enterprises Distribution, LLC
- Medos International SARL
- Megadyne Medical Products, Inc.
- Mentor Corporation
- Micrus Endovascular Corporation
- Molsaic Internal Venture
- Momenta Pharmaceuticals, Inc.
- NeoStrata Company, Inc.
- Neuravi Limited
- NeuWave Medical, Inc.
- Novira Therapeutics
- Omrix Biopharmaceuticals, Inc.
- Ortho Biotech Products, L.P.
- Ortho-McNeil, Inc.
- Orthotaxy
- Peninsula Pharmaceuticals, Inc.
- Pulsar Vascular Inc
- RespiVert Ltd.
- Scios, Inc.
- Selected Nerve Stimulation Internal Ventures
- Sentio, LLC
- Sequus Pharmaceuticals
- Stem Cell Internal Venture
- Synthes, Inc.
- Tibotec
- Torax Medical, Inc.
- Triage Medical, Inc.
- Verb Surgical Inc.
- Veridex
- Vigor Sub, Inc.
- Vistakon
- XO1 Limited
- TARIS Biomedical LLC
- Verb Surgical, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice